Research and Clinical Trials

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Researchers have developed an innovative mesothelioma testing strategy that could potentially increase the detection rate of cancer DNA in the blood.

Enhancing digital literacy and improving access to the internet and digital devices may make it easier for rural smokers to quit.

Dr. Michael Wallace, a Mayo Clinic interventional endoscopist, discusses pancreatic cancer screening and research advancements.

Dr. Keith Knutson discusses lung cancer vaccine research at Mayo Clinic and how physicians might use vaccines for other types of cancer.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Mark McNiven, Ph.D., and Tanios Bekaii-Saab, M.D., Mayo Clinic Comprehensive Cancer Center researchers, explain what cancer is, how it develops and why it's challenging to treat.

Findings show extended progression-free survival for people with meningiomas who received a radiopharmaceutical approved for neuroendocrine tumors.

Mayo Clinic study findings reveal a protein that increases glioblastoma malignancy, a new understanding of the tumor's biology, and a potential new treatment strategy.

Dr. Elizabeth Cathcart-Rake explains the value of specialized cancer care for LGBTQ+ people and how she hopes to pave the way for improved outcomes with the Rainbows Breast Cancer Clinic.